Impax Laboratories Inc. (IPXL)
Today's Range: 18.18 - 18.92 |
IPXL Avg Daily Volume: 1,210,000
|Last Update: 05/17/13 - 4:00 PM EDT
|YTD Performance: -9.03%
|Previous Close: $18.64
|52 Week Range: $14.41 -
|Oustanding Shares: 68,477,096
|Market Cap: 1,276,413,069
|Latest Dividend Yield:
|Price Earnings Ratio:
|Price Earnings Comparisons:
|Price Performance History (%Change):
|Earnings for IPXL:
Average Earnings Estimates
|Number of Analysts
|Growth Rate (Year over Year)
Impax Labs estimates and price target reduced at UBS
IPXL earnings estimates were reduced, said UBS. A new 483 warning letter had a lot more extensive issues, leading to uncertainty. Price target was reduced to $17.
Impax Laboratories downgraded at Canaccord
IPXL was downgraded from Buy to Hold, Canaccord Genuity said. $20 price target. FDA challenges have been expanded.
Impax Laboratories downgraded at Leerink
IPXL was downgraded to Market Perform, said Leerink. The FDA uncovered additional manufacturing deficiencies, creating uncertainty for the stock.
Impax Labs numbers boosted at BofA/Merrill
Shares of IPXL now seen reaching $25, according to Bank of America/Merrill Lynch said. Estimates also upped, as the company is seeing higher generic sales. Underperform rating.
Impax Laboratories downgraded at ThinkEquity
IPXL was downgraded from Buy to Hold, ThinkEquity said. Valuation call, based on a $25 price target.
Impax Laboratories numbers raised at Jefferies
Shares of IPXL now seen reaching $21, Jefferies said. Estimates also raised on expected fourth qaurter upside. Hold rating.
Impax Laboratories upgraded at Canaccord
IPXL was upgraded from Hold to Buy, Canaccord Genuity said. $28 price target. Stock could be at a positive inflection point.
I greatly appreciate the team for sharing my remembrance to Alan Abelson. It really did come from the heart.
I am becom...
I approach an earnings call as I do eating a lobster: tear it apart and leave nothing for the dogs in the back alley. ...
Real Money Pro Quick Links
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data
. Company fundamental data provided by Morningstar
. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.